$500,000 Awarded for Groundbreaking Duchenne Muscular Dystrophy Trial
In a landmark announcement, Duchenne UK and Parent Project Muscular Dystrophy (PPMD) have committed $500,000 to a pioneering Phase 1 clinical trial aimed at evaluating the safety and tolerability of muscle progenitor cells in patients with Duchenne Muscular Dystrophy (DMD). This trial represents a significant advancement in the quest to find effective treatments for this […]